Fellowship · Gainesville, FL
Sponsored by University of Florida College of Medicine
Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM.
The Lancet. Infectious diseases · 2025 · 323 citations · Cornelius Clancy
Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023 · 611 citations · Cornelius Clancy
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
The New England journal of medicine · 2021 · 1,404 citations · Nicole Iovine
Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022 · 436 citations · Cornelius Clancy
Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022 · 434 citations · Cornelius Clancy
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021 · 398 citations · Cornelius Clancy
Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients.
The Lancet. Respiratory medicine · 2024 · 108 citations · Cornelius Clancy
Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
Drugs · 2022 · 254 citations · Gary Wang